This is a Phase 1, multi-center, open-label study with a dose-escalation phase (Phase 1a) and a cohort expansion phase (Phase 1b), to evaluate the safety, tole…

Non Hodgkin LymphomaRichter TransformationMultiple Myeloma+10 more

~Estimated

~$10 – $8,750

Newave Pharmaceutical IncNCT04771572

Phase 1

A Phase 1, Open-Label, Dose Escalation and Expansion Study of STX-0712 in Patients With Advanced Hematologic Malignancies

This is a first-in-human, multicenter, open-label, phase 1 study to evaluate the safety, PK, PD and preliminary efficacy of STX-0712 in patients with advanced …

Chronic Myelomonocytic LeukemiaChronic Myelomonocytic Leukemia (CMML)Chronic Myelomonocytic Leukemia-1+9 more

~Estimated

~$10 – $8,750

Solu Therapeutics, IncNCT06950034